Consensus RaQualia Pharma Inc.

Equities

4579

JP3967150008

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-10 am EDT			5-day change	1st Jan Change
598 ^JPY	+0.50%		-0.17%	-13.08%

Mar. 26	RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	CI
Feb. 14	RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	CI

Evolution of the average Target Price on RaQualia Pharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

33c1d77c5b531a.zYIunlmzMz6JhUyWsD6xCYtIkS2qNf6r8hJU-CoTH6o.-bMd3zLRX1n6tS7lwXP-T-MLqW6bWqeGunkWjx1maf2X5BvKPetwBu38Jw~490e7ae555eb1e8f963abcff6a7e2425

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

598 JPY

Average target price

1,800 JPY

Spread / Average Target

+201.00%

High Price Target

1,800 JPY

Spread / Highest target

+201.00%

Low Price Target

1,800 JPY

Spread / Lowest Target

+201.00%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar